Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crowdstrike Holdings Inc (CRWD) vs Definium Therapeutics Inc. Common Shares (DFTX) Price & Performance

Crowdstrike Holdings IncTrade
Definium Therapeutics Inc. Common SharesTrade

Price performance (Past 24H)

Key statistics

Crowdstrike Holdings Inc vs Definium Therapeutics Inc. Common Shares — how do they compare? Crowdstrike Holdings Inc trades at $275.62 (market cap $269.31B), while Definium Therapeutics Inc. Common Shares trades at $36.8 (market cap $4.59B). The key difference: Crowdstrike Holdings Inc is far larger — about 58.7× Definium Therapeutics Inc. Common Shares's market cap, and Crowdstrike Holdings Inc is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Crowdstrike Holdings Inc for 97 Days and Definium Therapeutics Inc. Common Shares for 0 Days on average.

CRWDDFTX
Market Cap
$269.31B$4.59B
Volume
9,381,5602,103,937
Sector
TechnologyHealth
52-Week High
$278.86$48.45
52-Week Low
$87.56$10.68
Typical Hold Time
97 Days0 Days
Enterprise Value
$265.11B$3.55B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crowdstrike Holdings Inc

CrowdStrike (CRWD) trades at $275.04, up 3.62% today and near its all-time high, with a bullish technical signal from moving averages. The company shows strong revenue growth, reaching $3.95B in 2025, though net income remains negative at -$19.27M. Recent earnings beats and positive analyst sentiment (76% buy ratings) highlight momentum, while the stock trades at elevated valuation multiples like P/S of 49.86. Key developments include expansion into the OpenAI Marketplace and AI-driven cybersecurity demand.

Outlook: CrowdStrike's growth trajectory and AI positioning offer upside, but high valuations and profitability challenges pose risks. Analyst consensus target is $235.74, below current price, suggesting caution despite bullish sentiment. Competitive pressures and execution on net income conversion are critical for sustained gains.

Definium Therapeutics Inc. Common Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRWD
84% Buy16% Sell
Avg holding period · 97 Days
DFTX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Crowdstrike Holdings Inc

CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.

Read more on CRWD →

About Definium Therapeutics Inc. Common Shares

Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.

Read more on DFTX →